In dermatophytosis, which antifungal drug is not indicated :
**Question:** In dermatophytosis, which antifungal drug is not indicated:
A. Fluconazole
B. Terbinafine
C. Griseofulvin
D. Itraconazole
**Core Concept:** Dermatophytosis is a superficial fungal infection caused by dermatophytes, a group of fungi that primarily infect the skin, hair, and nails. Antifungal drugs are used to treat these infections. Different antifungal drugs target various aspects of fungal physiology, such as cell membrane synthesis, ergosterol biosynthesis, or protein synthesis.
**Why the Correct Answer is Right:** Fluconazole (A) is a triazole antifungal drug that primarily targets ergosterol biosynthesis in the fungal cell membrane, leading to membrane instability and cell death. It is effective against certain systemic fungal infections, but not against dermatophytosis because dermatophytes possess a unique type of ergosterol that is resistant to triazole inhibition.
**Why Each Wrong Option is Incorrect:**
B. Terbinafine (T) is also a triazole antifungal drug, similar to fluconazole. However, terbinafine is effective against dermatophytosis due to its ability to inhibit ergosterol biosynthesis, which is targeted by triazoles in general, including fluconazole.
C. Griseofulvin (G) is a macrocyclic lactone antifungal drug that targets fungal microtubules, impairing spindle assembly and cell division. While griseofulvin is effective against dermatophytosis, fluconazole is not because griseofulvin has a different mode of action compared to triazoles, which makes it suitable for treating dermatophytosis but not fluconazole.
D. Itraconazole (I) is another triazole antifungal drug that targets ergosterol biosynthesis in fungal cells. It is effective against dermatophytosis, just like terbinafine, but fluconazole is not due to the similar mode of action between itraconazole and terbinafine.
**Clinical Pearl:** Understanding the differences in drug mechanisms helps in selecting the appropriate antifungal agent for treating dermatophytosis. Fluconazole is not indicated for dermatophytosis because of its distinct mode of action compared to the triazoles, which makes griseofulvin, terbinafine, and itraconazole effective against dermatophytosis but not fluconazole.